News for Harmony Biosciences Holdings, Inc. (HRMY)

We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Capital Curiosity’s Substack by Taylor Nichols. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. (HRMY)’s share was trading at $35.03 as of 5th June. HRMY’s trailing and forward P/E were 13.37 and 9.45 respectively according to Yahoo […]

On May 15, 2025, Mizuho analyst Graig Suvannavejh announced the maintenance of the "Outperform" rating for Harmony Biosciences Holdings, represented by the stoc

Mizuho has elevated its price target for Harmony Biosciences (HRMY) from $44 to $48, maintaining an Outperform rating after the company's first-quarter report.

On May 7, 2025, Needham analyst Ami Fadia reiterated a "Buy" rating for Harmony Biosciences Holdings (HRMY), maintaining the price target at $49.00. This decisi

Net Product Revenue: $184.7 million, a 20% increase year over year.Net Income Growth: 19% increase compared to the prior-year quarter.Non-GAAP Adjusted Net Inc

Harmony Biosciences Holdings Inc (HRMY) showcases robust revenue growth and net income increase in Q1 2025.Strong product portfolio with WAKIX leading the char

May 06, 2025 / 12:30PM GMTOperator (Operator Instructions) Good morning. My name is Angela, and I will be your conference operator today. At this time, I would

The following slide deck was published by Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings (HRMY) has recently received a reaffirmed 'Buy' rating from Needham, an esteemed financial services firm. Analyst Ami Fadia confirm

Revenue: Achieved $184.7 million in net revenue for Q1 2025, surpassing the estimated $182.90 million and marking a 20% growth year-over-year.Earnings Per Shar

As of March 31, 2025, Harmony (HRMY) reported total cash, cash equivalents, and investments amounting to $610.2 million. This marks an increase from the $576.1

We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY. Harmony Biosciences Holdings, Inc. (HRMY)’s share was trading at $30.97 as of April 3rd. HRMY’s trailing and forward P/E were 12.34 and 8.72 respectively according to Yahoo […]

We came across a bullish thesis on Harmony Biosciences Holdings, Inc. (HRMY) on Value Investing Subreddit Page by Long-Access-2143. In this article, we will summarize the bulls’ thesis on HRMY.

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Ron Philip to the Company's Board of Directors. Ron Philip is the Preside

We recently published a list of 10 Best Small-Cap Stocks to Buy Before They Explode.  In this article, we are going to take a look at where Harmony Biosciences Holdings, Inc.

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Harmony Bi

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Harmony Biosci

We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are going to take a look at where Harmony Biosciences Holdings, Inc.

Summary Harmony Biosciences Holdings Inc (HRMY), a pharmaceutical company focused on innovative therapies for rare neurological diseases, announced its particip